Down-regulation of soluble guanylyl cyclase in the inner medulla of DOCA-salt hypertensive rats

Vascular Pharmacology

Volumn 40, Issue 3, 2003, Pages 155-160

  Taylor, Traci A ^a   Pollock, Jennifer S ^a   Pollock, David M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

cGMP; Deoxycorticosterone; Hypertension; Inner medulla

Indexed keywords

CYCLIC GMP; DEOXYCORTICOSTERONE ACETATE; GUANYLATE CYCLASE; PLACEBO; SODIUM CHLORIDE;

ANIMAL MODEL; ARTICLE; BETA CHAIN; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HYPERTENSION; IMPLANTATION; MEDULLA OBLONGATA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; URINALYSIS; URINARY EXCRETION; WESTERN BLOTTING;

EID: 0041833714     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1537-1891(03)00048-X     Document Type: Article

References (27)

1. Alberola A., Pinilla J.M., Quesada T., Romero J.C., Salom M.G., Salazar F.J. Role of nitric oxide in mediating renal responses to volume expansion. Hypertension. 19:1992;780-784.
2. Allcock G.H., Hukkanen M., Polak J.M., Pollock J.S., Pollock D.M. Increased nitric oxide synthase-3 expression in kidneys of deoxycorticosterone acetate-salt hypertensive rats. J. Am. Soc. Nephrol. 11:1999;2283-2289.
3. Andreopoulos S., Papapetropoulos A. Molecular aspects of soluble guanylyl cyclase regulation. Gen. Pharmacol. 34:2000;147-157.
4. Davis K.L., Martin E., Turko I.V., Murad F. Novel effects of nitric oxide. Annu. Rev. Pharmacol. Toxicol. 41:2001;203-236.
5. De Nicola L., Blantz R.C., Gabbai F.B. Nitric oxide and angiotnesin: II. glomerular and tubular interaction in the rat. J. Clin. Invest. 89:1992;1248-1256.
6. Filippov G., Bloch D.B., Bloch K.D. Nitric oxide stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells. J. Clin. Invest. 100:1997;942-948.
7. Friebe A., Schultz G., Koesling D. Stimulation of soluble guanylate cyclase by superoxide dismutase is mediated by NO. Biochem. J. 335:1998;527-531.
8. Gow A.J., Chen Q., Hess D.T., Day B.J., Ischiropoulos H., Stamler J.S. J. Biol. Chem. 277:2002;9637-9640.
9. 1 form of soluble guanylyl cyclase by nitric oxide. J. Clin. Invest. 100:1997;1488-1492.
10. Hirata Y., Matsuoka H., Suzuki E., Hayakawa H., Sugimoto T., Matsuda Y., Morishita Y., Kangawa K., Minamino N., Matsuo H. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Circulation. 887:1993;554-561.
11. Ishii N., Patel K.P., Lane P.H., Taylor T.A., Bian K., Murad F., Pollock J.S., Carmines P.K. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J. Am. Soc. Nephrol. 12:2001;1630-1639.
12. Jin X., Siragy H.M., Carey R.M. Renal interstitial cGMP mediates natriuresis by direct tubule mechanism. Hypertension. 38:2001;309-316.
13. Koesling D., Friebe A. Soluble guanylyl cyclase: structure and regulation. Rev. Physiol., Biochem. Pharmacol. 135:1999;41-65.
14. G-nitro-L-arginine methyl ester on renal function and blood pressure. Am. J. Physiol. 261:1991;F1033-F1037.
15. Lahera V., Navarro J., Biondi M.L., Ruilope L.M., Romero J.C. Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis. Am. J. Physiol. 264:1993;F344-F347.
16. Lee J., Kang D.G., Kook H., Kim I.K., Oh B.S. Differentially-altered vascular guanylate cyclase isoforms in experimental hypertensive rats. J. Korean Med. Sci. 14:1999;386-392.
17. Majid D.S., Williams A., Navar L.G. Inhibition of nitric oxide synthesis attenuates pressure-induced natriuretic responses in anesthetized dogs. Am. J. Physiol. 264:1993;F79-F87.
18. Marques M., Millas I., Jimenez A., Garcia-Colis E., Rodriguez-Feo J.A., Velasco S., Barrientos A., Casado S., Lopez-Farre A. Alteration of the soluble guanylate cyclase system in the vascular wall of lead-induced hypertension in rats. J. Am. Soc. Nephrol. 12:2001;2594-2600.
19. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol. Rev. 43:1991;109-142.
20. Murad F. Cyclic GMP: synthesis, metabolism, and function. Adv. Pharmacol. 26:1994;1-5.
21. Nuglozeh E., Gauquelin G., Garcia R., Tremblay J., Schiffrin E.L. Atrial natriuretic peptide receptors in renal papilla of DOCA-salt hypertensive rats. Am. J. Physiol. 259:1990;F130-F137.
22. Nuglozeh E., Mbikay M., Stewart D.J., Legault L. Gene expression of natriuretic peptide receptors in rats with DOCA-salt hypertension. Am. J. Physiol. 273:1997;C1227-C1434.
23. Pollock D.M., Allcock G.H., Krishnan A., Dayton B.D., Pollock J.S. Upregulation of endothelin B receptors in kidneys of DOCA-salt hypertensive rats. Am. J. Physiol. 278:2000;F279-F286.
24. Ruetten H., Zabel U., Linz W., Schmidt H.H.W. Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats. Circ. Res. 85:1999;534-541.
25. Shirasaki Y., Kolm P., Nickols G.A., Lee T.J. Endothelial regulation of cyclic GMP and vascular responses in hypertension. J. Pharmakol. Ther. 245:1988;53-58.
26. Theilig F., Bostanjoglo M., Pavenstadt H., Grupp C., Holland G., Slosarek I., Gressner A.M., Russwurm M., Koesling D., Bachmann S. Cellular distribution and function of soluble guanylyl cyclase in rat kidney and liver. J. Am. Soc. Nephrol. 12:2001;2209-2220.
27. Zabel U., Weeger M., La M., Schmidt H.H. Human soluble guanylyate cyclase: functional expression and revised isoenzyme family. Biochem. J. 335:1998;51-57.